n-methyl-3,4-methylenedioxyamphetamine and dopamine quinone

n-methyl-3,4-methylenedioxyamphetamine has been researched along with dopamine quinone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boxler, MI; Kraemer, T; Steuer, AE; Stock, L1

Other Studies

1 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and dopamine quinone

ArticleYear
Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine.
    Toxicology letters, 2016, Jan-22, Volume: 243

    Topics: Catechol O-Methyltransferase; Chromatography, Liquid; Deamination; Dopamine; Humans; Inhibitory Concentration 50; Monoamine Oxidase; Monoamine Oxidase Inhibitors; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; Reactive Oxygen Species; Serotonin; Tandem Mass Spectrometry

2016